The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells

With the emergence of Src inhibitors in clinical trials, improved knowledge of the molecular responses of cancer cells to these agents is warranted. This will facilitate the development of tests to identify patients who may benefit from these agents, allow drug activity to be monitored and rationali...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Purnell, P.R., Mack, P.C., Tepper, C.G., Evans, C.P., Green, T.P., Gumerlock, P.H., Lara, P.N., Gandara, D.R., Kung, H.J., Gautschi, O.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2716757/
https://ncbi.nlm.nih.gov/pubmed/19240653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31819c78fb
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki